封面
市场调查报告书
商品编码
1714632

显影剂-2025-2030 年全球预测

Contrast Media Market by Product Type, Imaging Modality, Form, Route of Administration, Application, End User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计显影剂市场规模在 2024 年将达到 65.7 亿美元,在 2025 年成长至 70.8 亿美元,复合年增长率为 8.00%,到 2030 年将达到 104.3 亿美元。

主要市场统计数据
基准年2024年 65.7亿美元
预计年份:2025年 70.8亿美元
预测年份 2030 104.3亿美元
复合年增长率(%) 8.00%

显影剂市场已成为现代诊断成像的重要组成部分,在提高各种医疗应用中的影像清晰度和准确性方面发挥关键作用。在对精确诊断程序和技术创新日益增长的需求的推动下,该领域近年来在产品供应和应用方法方面发生了重大变化。科学进步与监管进步相结合,为改进诊断影像技术铺平了道路,从而增强了疾病的检测、监测和治疗计划。

技术突破不断重塑市场动态,化合物配方和输送的改进使得诊断成像程序更加安全、有效。世界各地的医疗保健提供者正在利用这些进步来缩短手术时间并提高患者安全性。市场成长的关键驱动力是对早期诊断、精准医疗和微创治疗计划的关注。

对这一转型领域的分析表明,从研究机构到医疗设备製造商的每个相关人员都在推动技术创新和应用方面发挥着至关重要的作用。临床需求和技术力之间的相互作用为永续成长创造了强大的平台。随着全球对早期诊断认识的不断提高以及慢性病盛行率的上升,未来前景一片光明。该行业正在取得进一步的进步,这将彻底改变影像中心和医院应对诊断挑战的方式。这一不断发展的叙述为后续章节的更深入探讨奠定了基础,阐明了影响当前和未来市场格局、细分动态、区域影响力和主要企业的贡献的基本趋势。

改变显影剂市场

在强劲的技术创新和日益严格的监管标准的推动下,造影剂产业正经历巨大的变革时期。近年来,人们已经从传统的成像剂转向更专业的製剂,以提高诊断的准确性。研究的进步带来了分子成像的突破,使得生理过程的详细视觉化成为可能。这项创新转变使临床医生能够识别极小的异常,从而满足对高风险患者早期检测日益增长的需求。

数位技术和影像处理流程自动化的融合也正在再形成市场动态。人工智慧和机器学习在诊断成像领域的快速应用简化了数据分析并改善了解释,从而提高了影像品质和诊断信心。此外,官民合作关係和跨境合作的增加加速了产品开发并促进了全球标准化,为法规结构的协调铺平了道路。

此外,患者人口结构的变化以及慢性病的增加需要具有卓越安全性和功效的创新显影剂解决方案。随着新型显影剂在临床试验中不断表现出更好的性能,市场上的公司继续在研发方面投入大量资金,从而创造了一个竞争激烈、充满活力的环境。这种转变不仅会改善患者的治疗效果,还会加强市场在不断发展的医疗保健环境中对永续成长的承诺。

市场区隔分析的关键见解

彻底的市场区隔分析揭示了一条揭示显影剂市场多样化格局的有意义的途径。从产品类型来看,不同剂型针对不同的影像需求,包括钡剂显影剂、显影剂显影剂、碘剂、微气泡造影显影剂,每种剂型针对不同的影像场景而设计,在诊断准确性方面均具有独特的优势。从显像模式来看,市场可分为 CT(电脑断层扫描)、MRI(磁振造影)、光学影像、超音波和 X 光/萤光等部分,每种技术的需求各不相同。

按形式进一步细分錶明,市场是动态的而不是静态的,有液体、糊状和粉末形式可供选择,每种形式都适合特定的临床要求和患者情况。给药途径包括血管内、口服和直肠,可提供自订解决方案以满足不同患者的需求和通讯协定。按应用细分,凸显了推动采用显影剂的广泛临床状况,从癌症和心血管疾病到胃肠道、肌肉骨骼、肾臟和神经系统疾病。此外,考虑门诊手术中心、诊断影像中心和医院等最终用户的细分方法可以清楚地了解各个市场参与企业如何根据他们的特殊需求优化他们的服务产品。这种多层次的细分反映了市场的复杂性,并提供了消费者趋势和目标产品创新的关键见解,使相关人员能够做出明智的策略决策。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 由于慢性疾病和需要诊断影像的情况增加,对显影剂的需求也在增长
      • 医疗机构越来越多地采用先进的影像技术,推动了显影剂的需求
    • 限制因素
      • 显影剂的潜在副作用和过敏反应限制了其广泛使用
    • 机会
      • 显影剂配方的技术进步正在提高安全性、增强影像品质并创造新的成长前景
      • 医疗保健基础设施和诊断影像服务的扩展将推动新兴市场显影剂的使用增加
    • 任务
      • 新显影剂剂的监管障碍和核准流程延迟了市场进入
  • 市场区隔分析
    • 产品类型:钆基显影剂在医学影像中的用途与优势
    • 最终使用者:门诊手术中心显影剂使用量的增加
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章显影剂市场(依产品类型)

  • 介绍
  • 钡基显影剂
  • 钆基显影剂
  • 碘化显影剂
  • 微气泡显影剂

第七章显影剂市场(依影像方式)

  • 介绍
  • 电脑断层扫描(CT)
  • 磁振造影(MRI)
  • 光学成像
  • 超音波
  • X射线和萤光透视

第 8 章显影剂市场(按剂型)

  • 介绍
  • 液体
  • 贴上
  • 粉末

第九章显影剂市场(依管理途径)

  • 介绍
  • 血管内途径
  • 口服途径
  • 直肠途径

第 10 章显影剂市场(按应用)

  • 介绍
  • 癌症
  • 心血管疾病
  • 胃肠道疾病
  • 肌肉骨骼疾病
  • 肾臟疾病
  • 神经系统疾病

第 11 章显影剂市场(依最终用户划分)

  • 介绍
  • 门诊手术中心
  • 诊断影像中心
  • 医院

12.美洲显影剂市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太显影剂市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

14. 欧洲、中东和非洲显影剂市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Acro Lifesciences(I)Pvt. Ltd.
  • APOLLO RT Co. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Spa
  • Covis Group
  • Daiichi Sankyo Co. Ltd.
  • Fuji Pharma Co. Ltd.
  • GE Healthcare
  • Guerbet SA
  • iMAX Diagnostic Imaging Limited
  • JB Chemicals & Pharmaceuticals Limited
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • M.BIoTech Limited
  • MEDTRON AG
  • nanoPET Pharma GmbH
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • ulrich GmbH & Co. KG
  • Vitalquan, LLC
Product Code: MRR-434CCDA04E9E

The Contrast Media Market was valued at USD 6.57 billion in 2024 and is projected to grow to USD 7.08 billion in 2025, with a CAGR of 8.00%, reaching USD 10.43 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.57 billion
Estimated Year [2025] USD 7.08 billion
Forecast Year [2030] USD 10.43 billion
CAGR (%) 8.00%

The contrast media market has emerged as a pivotal component of modern diagnostic imaging, providing critical enhancements to the clarity and precision of images across a range of medical applications. This sector, driven by increasing demand for accurate diagnostic procedures and technological innovations, has seen a significant evolution in product offerings and application methodologies over recent years. A combination of scientific advancement and regulatory progress has paved the way for improved imaging techniques that enhance disease detection, monitoring, and treatment planning.

Technological breakthroughs are continuously reshaping the market dynamics, with improvements in compound formulation and administration methods leading to safer and more effective imaging experiences. Global healthcare providers are capitalizing on these advances to reduce procedural times and improve patient safety. At its core, the market's growth is fueled by the emphasis on early diagnosis, precision medicine, and minimally invasive intervention planning.

As we analyze this transforming arena, it becomes clear that every stakeholder, from research institutions to medical device manufacturers, plays an integral role in driving innovation and adoption. The interplay of clinical needs with technological capabilities creates a robust platform for sustainable growth. With heightened global awareness about early diagnosis and the rising prevalence of chronic diseases, the future outlook appears promising. The industry is on the cusp of further advances that are likely to revolutionize how imaging centers and hospitals approach diagnostic challenges. This evolving narrative sets the stage for deeper explorations in subsequent sections, illuminating the underlying trends, segmentation dynamics, regional influences, and key corporate contributions that shape the current and future market landscape.

Transformative Shifts in the Contrast Media Landscape

The contrast media industry is undergoing significant transformation, driven by robust technological innovation and heightened regulatory standards. Recent years have witnessed a departure from conventional imaging agents towards more specialized formulations that offer enhanced diagnostic precision. Research advancements have led to breakthroughs in molecular imaging, enabling a detailed visualization of physiological processes. Such transformative shifts are empowering clinicians to identify extra-small anomalies, thereby catering to the growing demand for early detection in high-risk patients.

Market dynamics have also been reshaped by the integration of digital technologies and automation in imaging processes. The rapid adoption of artificial intelligence and machine learning in diagnostic imaging has streamlined data analysis and improved interpretation, thus enhancing image quality and diagnostic reliability. Additionally, an increasing number of public-private partnerships and cross-border collaborations have resulted in accelerated product development and global standardizations, paving the way for harmonized regulatory frameworks.

Furthermore, the evolving patient demographics coupled with a rise in chronic disease prevalence have necessitated innovative contrast media solutions that offer superior safety profiles and efficacy. With clinical trials consistently affirming the enhanced performance of new contrast agents, market players continue to invest heavily in research and development endeavors, fostering a competitive yet dynamic environment. This transformation not only catalyzes improved patient outcomes but also reinforces the market's commitment to sustainable growth amid an ever-evolving healthcare landscape.

Key Insights from Market Segmentation Analysis

A thorough segmentation analysis reveals meaningful avenues that delineate the diverse landscape of the contrast media market. A review of product type distinctions shows that various formulations cater to different imaging needs, including Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media, each designed for tailored imaging scenarios with their own advantages in diagnostic precision. When examining by imaging modality, the market splits its focus into Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Optical Imaging, Ultrasound, and X-Ray & Fluoroscopy, underscoring varied demand across different technologies.

Further stratification by form indicates that the market is not static; it is dynamic and incorporates liquid, paste, and powder formats-each adapted to specific clinical requirements and patient profiles. The route of administration, whether through intravascular routes, the oral route, or the rectal route, further exemplifies custom solutions to meet diverse patient needs and procedural protocols. Application-based segmentation highlights a wide array of clinical conditions that drive the adoption of contrast agents, ranging from cancer and cardiovascular diseases to gastrointestinal, musculoskeletal, nephrological, and neurological disorders. Moreover, considering end users such as ambulatory surgical centers, diagnostic imaging centers, and hospitals, the segmentation approach showcases a clear understanding of how different market players optimize their service delivery based on specialized needs. This multi-layered segmentation reflects the market's complexity and provides critical insights into consumer trends and targeted product innovation, thereby allowing stakeholders to make informed, strategic decisions.

Based on Product Type, market is studied across Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media.

Based on Imaging Modality, market is studied across Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Optical Imaging, Ultrasound, and X-Ray & Fluoroscopy.

Based on Form, market is studied across Liquid, Paste, and Powder.

Based on Route of Administration, market is studied across Intravascular Route, Oral Route, and Rectal Route.

Based on Application, market is studied across Cancer, Cardiovascular Diseases, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals.

Regional Trends Shaping the Global Contrast Media Market

Geographically, the growth trajectory and future potential of the contrast media market are significantly driven by regional trends. In the Americas, a robust healthcare infrastructure combined with advanced diagnostic facilities has fostered a conducive environment for the rapid adoption of new contrast media agents, ensuring high returns on innovation investments. In the region spanning Europe, the Middle East & Africa, there is a deliberate move towards integrating comprehensive healthcare reforms with advanced imaging capabilities, paving the way for regulatory uniformity and technological progress.

Across Asia-Pacific, the market has exhibited remarkable dynamism with accelerated urbanization, rising healthcare awareness, and increased access to state-of-the-art diagnostic centers. The diverse healthcare landscape in these regions, marked by both developed and emerging markets, contributes to a broad spectrum of opportunities. This collective regional analysis provides strategic insights into tailoring solutions based on localized needs, ensuring relevance and efficacy across global markets.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights from Key Market Players in the Contrast Media Sector

The competitive landscape in the contrast media market is defined by a number of influential companies that lead in innovation and global outreach. Notable players include Acro Lifesciences (I) Pvt. Ltd., APOLLO RT Co. Ltd., Bayer AG, and Beijing Beilu Pharmaceutical Co., Ltd. Their contributions to product development, clinical research, and market penetration have been instrumental in setting industry benchmarks. Further, prominent companies such as Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., among others, have continuously broadened their portfolios through targeted investments and strategic partnerships.

The participation of Fuji Pharma Co. Ltd., GE Healthcare, and Guerbet SA illustrates a deep commitment to advancing imaging technologies and enhancing the safety and efficacy of diagnostic procedures. The industry also benefits from efforts by firms like iMAX Diagnostic Imaging Limited and J. B. Chemicals & Pharmaceuticals Limited, who have carved niches in specialized segments. Additionally, contributions from Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, MEDTRON AG, nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, ulrich GmbH & Co. KG, and Vitalquan, LLC further enrich the competitive tapestry. These companies, distinguished by their extensive research capabilities, strong distribution networks, and customer-centric innovations, create a robust ecosystem that supports consistent market growth and addresses critical diagnostic needs through specialized contrast media solutions.

The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., APOLLO RT Co. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare, Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, MEDTRON AG, nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, ulrich GmbH & Co. KG, and Vitalquan, LLC. Actionable Recommendations for Industry Leaders

Industry leaders must prioritize agility and continuous innovation to adapt to the rapidly changing contrast media landscape. It is crucial to invest in next-generation research for developing contrast agents that not only meet but exceed current safety and efficacy standards. Emphasizing collaboration across academic, clinical, and technological spheres can accelerate these advancements.

Leaders should incorporate strategic insights gained from segmentation and regional analyses to tailor product offerings and marketing strategies to specific market needs. Focusing on emerging regions with robust growth potential while leveraging established markets can balance risk with opportunity. Furthermore, companies are encouraged to streamline regulatory processes and establish proactive communication with healthcare authorities to expedite product approvals and market introduction.

Ultimately, enhancing cross-functional integration between research teams, marketing divisions, and sales channels will empower companies to navigate regulatory challenges more effectively and deliver solutions that resonate with end users. These targeted actions, rooted in data-driven insights and industry best practices, will foster sustainable growth and maintain competitive advantage in a rapidly evolving sector.

Conclusion: Navigating the Future of Contrast Media

The contrast media market is at a critical inflection point, where technological progress, enhanced safety standards, and evolving clinical demands converge to create a dynamic landscape ripe for innovation. Stakeholders across the value chain have an opportunity to harness cutting-edge research and tailored market strategies to drive the next wave of growth. Emphasis on precise segmentation, regional customization, and strategic corporate investments has laid a firm foundation for future developments. As the industry continues to advance, the ongoing dialogue between clinical needs and technological capabilities will be key to unlocking new levels of excellence in diagnostic imaging.

This comprehensive overview highlights the importance of adaptive strategies and proactive decision-making to meet the ever-changing needs of the healthcare ecosystem. By focusing on collaborative innovation and market-responsive strategies, industry leaders can secure not only competitive advantages but also improved patient outcomes and long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases and medical conditions requiring diagnostic imaging fueling the need for contrast agents
      • 5.1.1.2. Increasing adoption of advanced imaging technologies in healthcare facilities driving the demand for contrast media
    • 5.1.2. Restraints
      • 5.1.2.1. Potential side effects and allergic reactions associated with contrast media limiting their widespread usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in contrast media formulations offering improved safety profiles and better imaging quality creating new growth prospects
      • 5.1.3.2. Growing use of contrast media in emerging markets due to the expansion of healthcare infrastructure and diagnostic imaging services
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and approval processes for new contrast media formulations creating delays in market entry
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Applications and benefits of gadolinium-based contrast media in medical imaging
    • 5.2.2. End User: Growing use of contrast media in ambulatory surgical centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contrast Media Market, by Product Type

  • 6.1. Introduction
  • 6.2. Barium-based Contrast Media
  • 6.3. Gadolinium-based Contrast Media
  • 6.4. Iodinated Contrast Media
  • 6.5. Microbubble Contrast Media

7. Contrast Media Market, by Imaging Modality

  • 7.1. Introduction
  • 7.2. Computed Tomography (CT)
  • 7.3. Magnetic Resonance Imaging (MRI)
  • 7.4. Optical Imaging
  • 7.5. Ultrasound
  • 7.6. X-Ray & Fluoroscopy

8. Contrast Media Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Paste
  • 8.4. Powder

9. Contrast Media Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Intravascular Route
  • 9.3. Oral Route
  • 9.4. Rectal Route

10. Contrast Media Market, by Application

  • 10.1. Introduction
  • 10.2. Cancer
  • 10.3. Cardiovascular Diseases
  • 10.4. Gastrointestinal Disorders
  • 10.5. Musculoskeletal Disorders
  • 10.6. Nephrological Disorders
  • 10.7. Neurological Disorders

11. Contrast Media Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Hospitals

12. Americas Contrast Media Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Contrast Media Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Contrast Media Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. FDA approval of innovative syringe-less MRI contrast media injector catalyzes efficiency and eco-friendliness
    • 15.3.2. Beilu Pharma's EU GMP certification paves the way for contrast media expansion into global markets
    • 15.3.3. GE HealthCare's advancement in safer MRI imaging with manganese-based contrast agent innovation
    • 15.3.4. Sanochemia's strategic roll-out of Resotran marks a shift towards gadolinium-free MRI contrast agents and enhanced liver diagnostics
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acro Lifesciences (I) Pvt. Ltd.
  • 2. APOLLO RT Co. Ltd.
  • 3. Bayer AG
  • 4. Beijing Beilu Pharmaceutical Co., Ltd.
  • 5. Bracco Spa
  • 6. Covis Group
  • 7. Daiichi Sankyo Co. Ltd.
  • 8. Fuji Pharma Co. Ltd.
  • 9. GE Healthcare
  • 10. Guerbet SA
  • 11. iMAX Diagnostic Imaging Limited
  • 12. J. B. Chemicals & Pharmaceuticals Limited
  • 13. Jodas Expoim Pvt. Ltd.
  • 14. Lantheus Medical Imaging, Inc.
  • 15. M.Biotech Limited
  • 16. MEDTRON AG
  • 17. nanoPET Pharma GmbH
  • 18. SANOCHEMIA Pharmazeutika GmbH
  • 19. Spago Nanomedical AB
  • 20. Trivitron Healthcare
  • 21. ulrich GmbH & Co. KG
  • 22. Vitalquan, LLC

LIST OF FIGURES

  • FIGURE 1. CONTRAST MEDIA MARKET MULTI-CURRENCY
  • FIGURE 2. CONTRAST MEDIA MARKET MULTI-LANGUAGE
  • FIGURE 3. CONTRAST MEDIA MARKET RESEARCH PROCESS
  • FIGURE 4. CONTRAST MEDIA MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRAST MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 288. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2024